177 related articles for article (PubMed ID: 7905280)
1. The effect of MDR-1 gene expression on outcome in acute myeloblastic leukaemia.
Holmes JA; West RR
Br J Cancer; 1994 Feb; 69(2):382-4. PubMed ID: 7905280
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric assessment of multidrug resistance (MDR) phenotype in acute myeloid leukaemia.
Hart SM; Ganeshaguru K; Lyttelton MP; Prentice HG; Hoffbrand AV; Mehta AB
Leuk Lymphoma; 1993 Oct; 11(3-4):239-48. PubMed ID: 7903178
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of P-glycoprotein expression in haematological malignancies.
Nooter K; Sonneveld P
Leuk Res; 1994 Apr; 18(4):233-43. PubMed ID: 7909572
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16 or FAB M4Eo subtype.
Zöchbauer S; Haas OA; Schwarzinger I; Lechner K; Pirker R
Lancet; 1994 Sep; 344(8926):894. PubMed ID: 7916430
[No Abstract] [Full Text] [Related]
5. Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.
Gruber A; Vitols S; Norgren S; Areström I; Peterson C; Björkholm M; Reizenstein P; Luthman H
Br J Cancer; 1992 Aug; 66(2):266-72. PubMed ID: 1380280
[TBL] [Abstract][Full Text] [Related]
6. Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications.
Kuss BJ; Deeley RG; Cole SP; Willman CL; Kopecky KJ; Wolman SR; Eyre HJ; Lane SA; Nancarrow JK; Whitmore SA
Lancet; 1994 Jun; 343(8912):1531-4. PubMed ID: 7911871
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of multidrug resistant MDR1 transcript in acute myeloid leukaemia by non-isotopic quantitative cDNA-polymerase chain reaction.
Lyttelton MP; Hart S; Ganeshaguru K; Hoffbrand AV; Mehta AB
Br J Haematol; 1994 Mar; 86(3):540-6. PubMed ID: 7913825
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance (MDR) genes in haematological malignancies.
Nooter K; Sonneveld P
Cytotechnology; 1993; 12(1-3):213-30. PubMed ID: 7765326
[TBL] [Abstract][Full Text] [Related]
9. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukemia.
Michieli M; Damiani D; Geromin A; Michelutti A; Fanin R; Raspadori D; Russo D; Visani G; Dinota A; Pileri S
Eur J Haematol; 1992 Feb; 48(2):87-92. PubMed ID: 1347749
[TBL] [Abstract][Full Text] [Related]
11. Correlation of mdr status with clinical outcome in patients with acute myeloblastic leukemia.
Holmes JA; West RR; Whittaker JA; Jacobs A
Br J Haematol; 1991 Jan; 77(1):130-1. PubMed ID: 1671820
[No Abstract] [Full Text] [Related]
12. Classical multidrug resistance in acute myeloid leukaemia.
Paietta E
Med Oncol; 1997 Mar; 14(1):53-60. PubMed ID: 9232613
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the mdr1 gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A.
Nooter K; Sonneveld P; Oostrum R; Herweijer H; Hagenbeek T; Valerio D
Int J Cancer; 1990 Feb; 45(2):263-8. PubMed ID: 1968051
[TBL] [Abstract][Full Text] [Related]
14. Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia.
Pallis M; Turzanski J; Harrison G; Wheatley K; Langabeer S; Burnett AK; Russell NH
Br J Haematol; 1999 Feb; 104(2):307-12. PubMed ID: 10050713
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance: clinical relevance in acute leukemia.
List AF
Oncology (Williston Park); 1993 Oct; 7(10):23-8, 32; discussion 32, 35-8. PubMed ID: 7902728
[TBL] [Abstract][Full Text] [Related]
16. Failure to detect the P-glycoprotein multidrug resistant phenotype in cases of resistant childhood acute lymphocytic leukaemia.
Ubezio P; Limonta M; D'Incalci M; Damia G; Masera G; Giudici G; Wolverton JS; Beck WT
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1895-9. PubMed ID: 2576650
[No Abstract] [Full Text] [Related]
17. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
18. Studies on low-level MDR cells.
Belvedere G; Dolfini E
Cytotechnology; 1993; 12(1-3):257-64. PubMed ID: 7765328
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance (MDR1) in acute myelogenous leukemia: is it time to test?
Baccarani M; Michieli M; Damiani D; Michelutti A
Blood; 1992 Aug; 80(4):1094-5. PubMed ID: 1353994
[No Abstract] [Full Text] [Related]
20. Genetic aspects of multidrug resistance.
Pauly M; Ries F; Dicato M
Med Oncol Tumor Pharmacother; 1992; 9(1):21-4. PubMed ID: 1364127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
